Final Efficacy and Safety Results of Pyrotinib Combined With Trastuzumab and Chemotherapy in Pre-Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.

Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.

Related documents

• Reduced susceptibility to triclosan and proposed epidemiological cut-off values for disinfectants and heavy metals in Escherichia coli isolated from Thai tilapia farms: Implications for One Health antimicrobial resistance surveillance.#1039988
• Edible coatings and films in meat preservation: Materials, functional mechanisms, and technological challenges.#1039989
• Palm Vein Biometrics A Rapid Patient Identification Tool for Emergency and Trauma Care.#1039990
• Directions for Establishing a Korean National One Health Joint Plan of Action: Focusing on Zoonotic Disease Preparedness and Response.#1039991
• Intensive arable farming calls for resilient wild bee restoration amid severe abundance fluctuations.#1039992